Paul A. Keire, Ph.D.
Affiliations: | 2009 | University of Washington, Seattle, Seattle, WA |
Area:
Pathology, Biomedical EngineeringGoogle:
"Paul Keire"Parents
Sign in to add mentor| Thomas N. Wight | grad student | 2009 | University of Washington | |
| (The role of versican in the biology of smooth muscle cells and in the engineering of elastin rich blood vessel substitutes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Keire PA, Bressler SL, Mulvihill ER, et al. (2015) Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo. Matrix Biology : Journal of the International Society For Matrix Biology |
| Keire PA, Bressler SL, Lemire JM, et al. (2014) A role for versican in the development of leiomyosarcoma. The Journal of Biological Chemistry. 289: 34089-103 |
| Stuelsatz P, Keire P, Almuly R, et al. (2012) A contemporary atlas of the mouse diaphragm: myogenicity, vascularity, and the Pax3 connection. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 60: 638-57 |
| Keire PA, L'Heureux N, Vernon RB, et al. (2010) Expression of versican isoform V3 in the absence of ascorbate improves elastogenesis in engineered vascular constructs. Tissue Engineering. Part A. 16: 501-12 |
| L'Heureux N, Dusserre N, Konig G, et al. (2006) Human tissue-engineered blood vessels for adult arterial revascularization. Nature Medicine. 12: 361-5 |
| KEIRE P, LHEUREUX N, VERNON R, et al. (2006) The use of proteoglycans to bioengineer elastin rich tissue Matrix Biology. 25: S11-S12 |